本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Avalo Therapeutics Inc

16.32
+0.24501.52%
成交量:56.66萬
成交額:924.27萬
市值:8.75億
市盈率:-3.70
高:16.57
開:16.17
低:15.87
收:16.07
52周最高:24.27
52周最低:9.54
股本:5,363.00萬
流通股本:4,014.95萬
量比:0.61
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-4.4100
每股收益(LYR):-5.8400
淨資產收益率:-36.27%
總資產收益率:-18.50%
市淨率:1.95
市盈率(LYR):-2.79

資料載入中...

2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/23

重要事件披露

Form 8-K - Current report
2026/03/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

SEC問詢函

Form CORRESP - Correspondence